MARLBOROUGH, Mass.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq:EXAS) today announced its financial results for the quarter ended March 31, 2009. Exact reported total revenues of $1.0 million for the first quarter of 2009, compared to total revenues of $51,000 during the same period of 2008. Total revenues increased due to the company’s recently announced strategic relationship with Genzyme Corp. Exact in January entered into an intellectual property transaction with Genzyme that generated $17.2 million in cash. The $17.2 million from Genzyme will be recognized as revenue over 20 quarters as a non-cash allocation.
